Hopital Saint Louis, Service D Oncologie Medicale

Paris 75475

0 studies enrolling now · 4 studies all time

What they study most

Prostatic Neoplasms, Castration-Resistant, Solid Tumors, Triple-Negative Breast Cancer, Tumors

Studies at this site

• A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen — Completed
• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed
• A Study of Atezolizumab in Advanced Solid Tumors — Completed
• A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors — Completed